InvestSMART

Orthocell Limited (ASX: OCC) - Announcements

Current share price for OCC : $0.765 0.005 (0.65%)+

ASX company news and announcements for Orthocell Limited (OCC) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Orthocell Limited (OCC) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Orthocell Limited (OCC), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Orthocell Limited (OCC)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$208 Orthocell Granted CelGro Patent Protection in Canada 16 Oct 2017 9:31AM $0.290 $0.765 risen by 163.79%
$208 Notice of Annual General Meeting/Proxy Form 13 Oct 2017 1:16PM $0.300 $0.765 risen by 155%
$208 Surgical Specialties Appointed as Exclusive Distributor 11 Oct 2017 8:17AM $0.280 $0.765 risen by 173.21%
$208 Orthocell Receives New Patent for Celgro Platform Technology 21 Sep 2017 9:07AM $0.340 $0.765 risen by 125%
$208 Appendix 4G 14 Sep 2017 9:59AM $0.335 $0.765 risen by 128.36%
$208 Annual Report to shareholders 14 Sep 2017 9:58AM $0.335 $0.765 risen by 128.36%
$208 Celgro Positive Safety and Performance in Human Hip Study 6 Sep 2017 9:27AM $0.305 $0.765 risen by 150.82%
$208 1st Patient Recruited in Ortho-ATI Shoulder Tendon Study 5 Sep 2017 8:26AM $0.300 $0.765 risen by 155%
$208 Preliminary Final Report 31 Aug 2017 12:30PM $0.280 $0.765 risen by 173.21%
$208 Change of Director's Interest Notice SW 8 Aug 2017 11:41AM $0.305 $0.765 risen by 150.82%
$208 Change of Director's Interest Notice PA 8 Aug 2017 11:40AM $0.305 $0.765 risen by 150.82%
$208 Change of Director's Interest Notice MC 8 Aug 2017 11:39AM $0.305 $0.765 risen by 150.82%
$208 Appendix 4C - quarterly 31 Jul 2017 6:59PM $0.310 $0.765 risen by 146.77%
$208 Change of Director's Interest Notice PA 25 Jul 2017 9:34AM $0.330 $0.765 risen by 131.82%
$208 Change of Director's Interest Notice MC 24 Jul 2017 10:57AM $0.340 $0.765 risen by 125%
$208 Change of Director's Interest Notice SW 24 Jul 2017 10:55AM $0.340 $0.765 risen by 125%
$208 Appendix 3B 20 Jun 2017 8:24AM $0.350 $0.765 risen by 118.57%
$208 Ortho-ACI on Australian Register of Therapeutic Goods 30 May 2017 9:12AM $0.370 $0.765 risen by 106.76%
$208 Ethics Approval Received for Pilot Ortho-ATI Tendon Study 1 May 2017 9:09AM $0.415 $0.765 risen by 84.34%
$208 Appendix 4C - quarterly 28 Apr 2017 6:52PM $0.415 $0.765 risen by 84.34%
$208 Response to ASX Query 11 Apr 2017 9:35AM $0.495 $0.765 risen by 54.55%
$208 Response to ASX Price and Volume Query 10 Apr 2017 4:44PM $0.440 $0.765 risen by 73.86%
$208 Singapore Patent for CelGro SMART Graft Received 28 Mar 2017 8:27AM $0.395 $0.765 risen by 93.67%
$208 Appendix 3B 22 Mar 2017 8:06PM $0.415 $0.765 risen by 84.34%
$208 Half Yearly Report and Accounts 28 Feb 2017 2:54PM $0.435 $0.765 risen by 75.86%

626 - 650 of 762 results

Page 26 of 31

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.